Vitamin D supplementation to improve laying hen robustness, longevity, and egg quality
补充维生素 D 可提高蛋鸡的健壮性、寿命和鸡蛋质量
基本信息
- 批准号:576766-2022
- 负责人:
- 金额:$ 3.7万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Alliance Grants
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This partnership aims to improve the robustness of laying hens to better cope with nutritional, immune, and environmental stresses and thus improve their productivity and longevity in a context of lengthening of laying cycles. Indeed, successfully keeping the laying hens to 100 weeks is no longer the exception and there is a tendency for extending the laying hens cycle of commercial flocks to reach 500 eggs per cycle. The long-life laying hen are expecting helping saving costs in production, create additional value and profit, improve the welfare of the chicken, and reduce the environmental impact of egg production. However, the main reason to deplete a flock is not often related to the persistency in egg production, but because of eggshell quality that gradually goes down with age. Poor quality eggs, and especially weaker shells, can increase the costs of egg packing and customer complaints. This is probably the result of the osteoporosis that occurs with ageing that may lead to both welfare issues and financial losses. Recent results have showed an increase expression of Fibroblast Growth Factor 23 (FGF23) and a decreased plasma levels of 1.25(OH)2D3, the active form of vitamin D, with ageing (Gloux). Vitamin D is a well-known essential nutrient in laying hens which contributes to bone mineralization and mobilization by promoting the intestinal absorption of Ca and P and thus ensures good shell quality (Bar, 2008). Vitamin D could thus help extending the laying cycle while reducing the potential negative impact for the hen. Beyond the interest of vitamin D for the health of laying hens, studies have shown the possibility of biofortification in vitamin D in eggs for human health. The specific objectives of this partnership will be to test the addition of a vitamin D in a more active form up to 90 weeks of laying in terms on its prophylactic effect on phosphorus and calcium status, gut health, and immunity and overall performances.
该伙伴关系旨在提高蛋鸡的健壮性,以更好地应对营养、免疫和环境压力,从而在延长产蛋周期的背景下提高其生产力和寿命。事实上,成功地将蛋鸡保持在100周不再是例外,而且有一种趋势,即延长商业鸡群的蛋鸡周期,使其达到每个周期500个蛋。长寿命蛋鸡有望帮助节省生产成本,创造附加值和利润,提高鸡的福利,并减少鸡蛋生产对环境的影响。然而,耗尽鸡群的主要原因通常与产蛋的持久性无关,而是因为蛋壳质量随着年龄的增长而逐渐下降。劣质鸡蛋,尤其是蛋壳较弱的鸡蛋,会增加鸡蛋包装的成本和顾客的投诉。这可能是随着年龄增长而出现的骨质疏松症的结果,这可能会导致福利问题和经济损失。最近的研究结果显示,随着年龄的增长,成纤维细胞生长因子23 (FGF23)的表达增加,血浆中1.25(OH)2D3(维生素D的活性形式)的水平降低(Gloux)。维生素D是一种众所周知的蛋鸡必需营养素,通过促进肠道对钙和磷的吸收,有助于骨矿化和动员,从而确保良好的蛋壳质量(Bar, 2008)。因此,维生素D可以帮助延长产蛋周期,同时减少对母鸡的潜在负面影响。除了维生素D对蛋鸡健康的好处之外,研究还表明,在鸡蛋中生物强化维生素D对人类健康也有可能。此次合作的具体目标是测试在产蛋90周内以更活跃的形式添加维生素D对仔猪磷和钙状态、肠道健康、免疫力和整体生产性能的预防作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LétourneauMontminy, MariePierreMP其他文献
LétourneauMontminy, MariePierreMP的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LétourneauMontminy, MariePierreMP', 18)}}的其他基金
Holistic vitamin strategy to improve the robustness of pigs
提高猪的健壮性的整体维生素策略
- 批准号:
571343-2021 - 财政年份:2022
- 资助金额:
$ 3.7万 - 项目类别:
Alliance Grants
Post-pandemic sustainability of the Canadian pork industry: upgrading by-products to added-value goods. From feed to food and advanced purified hydrogels for cosmetics and health
加拿大猪肉业大流行后的可持续性:将副产品升级为附加值产品。
- 批准号:
570672-2021 - 财政年份:2022
- 资助金额:
$ 3.7万 - 项目类别:
Alliance Grants
相似海外基金
RestEaze: A Novel Wearable Device and Mobile Application to Improve the Diagnosis and Management of Restless Legs Syndrome in Pediatric Patients with Attention Deficit/Hyperactivity Disorder
RestEaze:一种新型可穿戴设备和移动应用程序,可改善注意力缺陷/多动症儿科患者不宁腿综合症的诊断和管理
- 批准号:
10760442 - 财政年份:2023
- 资助金额:
$ 3.7万 - 项目类别:
Redox manipulation of iron to improve glioblastoma therapy: A phase 1 trial
铁的氧化还原操作可改善胶质母细胞瘤治疗:1 期试验
- 批准号:
10651509 - 财政年份:2023
- 资助金额:
$ 3.7万 - 项目类别:
Modulating Cellular Bioenergetics to Improve Skeletal Health
调节细胞生物能量以改善骨骼健康
- 批准号:
10661806 - 财政年份:2022
- 资助金额:
$ 3.7万 - 项目类别:
Targeting cellular senescence with oral fisetin supplementation to improve vascular aging
通过口服非瑟酮补充剂对抗细胞衰老,改善血管老化
- 批准号:
10538199 - 财政年份:2022
- 资助金额:
$ 3.7万 - 项目类别:
A multi-component non-pharmacological intervention to improve cognitive outcomes in hematologic cancer survivors
一种多成分非药物干预措施,可改善血液癌症幸存者的认知结果
- 批准号:
10437361 - 财政年份:2022
- 资助金额:
$ 3.7万 - 项目类别:
Modulating Cellular Bioenergetics to Improve Skeletal Health
调节细胞生物能量以改善骨骼健康
- 批准号:
10527457 - 财政年份:2022
- 资助金额:
$ 3.7万 - 项目类别:
Trial of Darbepoetin plus slow-release intravenous iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants
达贝泊汀联合缓释静脉铁剂减少输血、改善早产儿铁状态和神经发育的试验
- 批准号:
10662182 - 财政年份:2022
- 资助金额:
$ 3.7万 - 项目类别:
Trial of Darbepoetin plus slow-release intravenous iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants
达贝泊汀联合缓释静脉铁剂减少输血、改善早产儿铁状态和神经发育的试验
- 批准号:
10340574 - 财政年份:2022
- 资助金额:
$ 3.7万 - 项目类别:
Targeting cellular senescence with oral fisetin supplementation to improve vascular aging
通过口服非瑟酮补充剂对抗细胞衰老,改善血管老化
- 批准号:
10812313 - 财政年份:2022
- 资助金额:
$ 3.7万 - 项目类别:
Spatially responsive mass vaccination strategies for urban rabies
城市狂犬病的空间响应大规模疫苗接种策略
- 批准号:
10606567 - 财政年份:2022
- 资助金额:
$ 3.7万 - 项目类别:














{{item.name}}会员




